Cardiology Journal Articles from the International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

LEARN MORE

Topic search: CARDIOLOGY

Search the Journal's archive for all articles tagged as being related to your selected topic. Click here to return to the list of all topics.

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Cardiology Journal Articles
Amlodipine Besylate Veterinary Suspension Allen Loyd V Jr	May/Jun 2024 Pg. 242
Diltiazem 5% in Lipoderm, Veterinary Allen Loyd V Jr	May/Jun 2024 Pg. 244
Major Study Affirming the Relative Safety of Testosterone-replacement Therapy Biundo Bruce	Sep/Oct 2023 Pg. 358-360
Compounding Metformin for Use in Functional Medicine Desai Sarina, Thompson Tara	Sep/Oct 2023 Pg. 362-366
Losartan Potassium 2.5-mg/mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2023 Pg. 326
Formulation and In Vitro Evaluation of a Ramipril Entrapped in a Microsponge-based Drug-delivery System Taghi Hassanien Sagban, Abdulbaqi Mustafa R, Samein Laith Hamza, Rahmani Maha H Philip	Jul/Aug 2023 Pg. 340-346
Timolol 0.125%/Mucolox 15%/0.9% Normal Saline Nasal Spray Allen Loyd V Jr	Mar/Apr 2023 Pg. 153
Diazoxide 10-mg/mL in Oral Mix SF Allen Loyd V Jr	Nov/Dec 2022 Pg. 510
Intravenous Physical Compatibility of Heparin Sodium and Furosemide Maktabi Briana, Howard Mitchell S, Baki Gabriella, Churchwell Mariann D	Nov/Dec 2022 Pg. 522-526
A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans Riepl Mike	Sep/Oct 2022 Pg. 364-368
Furosemide 5-mg/mL Oral Suspension Allen Loyd V Jr	Jul/Aug 2022 Pg. 321-322
Hydralazine Hydrochloride 10 mg/mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2022 Pg. 323-324
Candesartan Cilexitil 1 mg/mL Syrup Allen Loyd V Jr	May/Jun 2022 Pg. 234
Propranolol 2 mg/mL and 5 mg/mL in Ora-Blend SF Suspension Allen Loyd V Jr	Mar/Apr 2022 Pg. 148
Comparison of Solvent Casting and Spray Casting Method on Compounding of an Orally Disintegrating Film Containing Amlodipine Besylate Ruslan Mohamad Fariz Haiqal, Janakiraman Ashok Kumar, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai	Mar/Apr 2022 Pg. 155-162
Enalapril Maleate 1 mg-mL in Ora-Plus and Ora-Sweet Suspension Allen Loyd V Jr	Jan/Feb 2022 Pg. 56
Kayexalate in Lactulose Allen Loyd V Jr	Nov/Dec 2021 Pg. 501
Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 503
Propranolol 2 mg/mL or 5 mg/mL in Ora-Sweet Allen Loyd V Jr	Nov/Dec 2021 Pg. 504
Cilazapril 1-mg/mL in Ora-Blend Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 413
Clonidine 0.01-mg/mL in Ora-Blend Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 414
Spironolactone 2-mg/mL or 2-5.mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Sep/Oct 2021 Pg. 421
Apixaban 0.25-mg/mL Suspension for Enteral Feeding Tube Allen Loyd V Jr	Jul/Aug 2021 Pg. 320
Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored Allen Loyd V Jr	Jul/Aug 2021 Pg. 327
Valsartan 4-mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jul/Aug 2021 Pg. 329
Stability Evaluation of Minoxidil in FOAMIL Foam Base with Bracketing Study Design Lupatini Rodrigo, Sidhu Raman, Patel Harshad, Bichar Katia	May/Jun 2021 Pg. 236-240
Amlodipine 1-mg/mL in Oral Mix Suspension Allen Loyd V Jr	Mar/Apr 2021 Pg. 142
Stability of Extemporaneously Compounded Nadolol 10-mg/mL Suspension in Oral Mix in Glass and Plastic Bottles and Plastic Syringes Walsh Andrea, Ziegler Blake, Lingertat-Walsh Karen, Law Shirley, Walker Scott E	Mar/Apr 2021 Pg. 163-168
Cyclophosphamide 10 mg/mL in Oral-Plus or Simple Syrup Suspension Allen Loyd V Jr	Jan/Feb 2021 Pg. 45
Diclofenac Sodium 5 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jan/Feb 2021 Pg. 46
Lisinopril 1 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jul/Aug 2020 Pg. 318
Alcohol-free Extemporaneous Formulations of Furosemide Are Chemically and Physically Stable in Ora-Blend Products for 30 Days Svirskis Darren, Jaffer Johaina, Agarwal Priyanka, Khan Ayeshah, Kaur Jaskarn, Cheng Alan, Hanning Sara	May/Jun 2020 Pg. 246-251
Acetazolamide 25 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2020 Pg. 130
Quinidine Sulfate 10 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2020 Pg. 136
Valsartan 4 mg/mL in Syrup NF Allen Loyd V Jr	Mar/Apr 2020 Pg. 139
Amiodarone Hydrochloride 5 mg/mL in SyrSpend SF pH4 Cherry Flavored Allen Loyd V Jr	Jan/Feb 2020 Pg. 54
Potassium Chloride 1 mmol/mL in Ora-Sweet SF Allen Loyd V Jr	Jan/Feb 2020 Pg. 61
Long-term Physicochemical Stability of Concentrated Solutions of Isosorbide Dinitrate in Polypropylene Syringes for Administration in the Intensive Care Unit Lardinois Benjamin, Dimitriou Alexandre, Delcave Charlotte, Soumoy Laura, Jamart Jacques, Bihin Benoît, Hecq Jean-Daniel, Galanti Laurence M	Jan/Feb 2020 Pg. 64-68
Verapmail Hydrochloride 50 mg/mL in SyrSpend SF Allen Loyd V Jr	Nov/Dec 2019 Pg. 494
Physicochemical Stability of Compounded Amlodipine Besylate Suspensions in PCCA Base, SuspendIt Graves Richard A, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Swopes Demikka, Morris Tommy C, Pramar Yashoda V	Nov/Dec 2019 Pg. 519-527
Dipyridamole 10 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Sep/Oct 2019 Pg. 408
Valsartan 4 mg/mL in Vehicle for Oral Solution USP Allen Loyd V Jr	Sep/Oct 2019 Pg. 412
Verapamil Hydrochloride 50 mg/mL in Ora-Plus:Ora-Sweet (1:1) Allen Loyd V Jr	Sep/Oct 2019 Pg. 413
Stability of Furosemide 5 mg/mL in Polypropylene Syringes van der Schaar JAJ, Grouls R, Franssen EJF, Crul M	Sep/Oct 2019 Pg. 414-417
Long-term Physiochemical Stability of Concentrated Solutions of Salbutamol (Albuterol) in Polypropylene Syringes for Use in the Intensive Care Unit and in Obstetrics Lardinois Benjamin, Baltzis Alexandre, Delcave Charlotte, Soumoy Laura, Jamart Jacques, Bihin Benoît, Hecq Jean-Daniel, Galanti Laurence	Sep/Oct 2019 Pg. 434-437
Candesartan Cilexetil 1 mg/mL in Syrup NF or Vehicle for Oral Solution USP Allen Loyd V Jr	Jul/Aug 2019 Pg. 315
Extemporaneous Indomethacin Oral Suspension Prepared from Injectable Ampules for Therapy in Premature Infants and Pediatric Patients de Lafuente Yanina, García Mónica Cristina, Jiminez-Kairuz Alvaro	Jul/Aug 2019 Pg. 324-331
Clopidogrel 5 mg/mL in a Sugar-Free Syrup Allen Loyd V Jr	May/Jun 2019 Pg. 232
Valsartan 16-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2019 Pg. 237
Amlodipine 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Mar/Apr 2019 Pg. 147
Captopril 0.8 mg/mL in SyrSpend SF Oral Suspension Allen Loyd V Jr	Mar/Apr 2019 Pg. 148
Rosuvastatin 20-mg/5-mL Oral Suspension Allen Loyd V Jr	Mar/Apr 2019 Pg. 152
Evaluation of the Physicochemical Stability of Amiodarone Hydrochloride in Syringes for the Intensive Care Unit Lardinois Benjamin, Dimitriou Alexandre, Delcave Charlotte, Jamart Jacques, Bihin Benoît, Soumoy Laura, Hecq Jean-Daniel, Galanti Laurence M	Mar/Apr 2019 Pg. 163-166
Magnesium Sulfate and Lidocaine Hydrochloride Injection in Prefilled Syringes Allen Loyd V Jr	Jan/Feb 2019 Pg. 55
Minoxidil 1-mg/mL in Ora-Plus and Ora-Sweet SF Suspension Allen Loyd V Jr	Jan/Feb 2019 Pg. 57
Stability of Compounded Ursodiol Suspensions in PCCA Base, SuspendIt Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Miller Valicia, Morris Tommy C, Graves Richard A	Jan/Feb 2019 Pg. 70-76
Diltiazem Hydrochloride 12 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2018 Pg. 493
Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2018 Pg. 494
Torsemide 5 mg/mL in Ora-Plus:Ora-Sweet Suspension Allen Loyd V Jr	Sep/Oct 2018 Pg. 411
Minoxidil 50 mg/mL in Espumil Foam Base Allen Loyd V Jr	Jul/Aug 2018 Pg. 322
Pentoxifylline 5% in Dermabase Allen Loyd V Jr	Jul/Aug 2018 Pg. 324
Propranolol Hydrochloride 1 mg/mL in SyrSpend SF Oral Suspension Allen Loyd V Jr	Jul/Aug 2018 Pg. 325
Long-term Physicochemical Stability of Concentrated Solutions of Noradrenaline Bitartrate in Polypropylene Syringes for Administration in the Intensive Care Unit Lardinois Benjamin, Pector Johan, Delcave Charlotte, Soumoy Laura, Jamart Jacques, Bihin B, Hecq Jean-Daniel, Galanti Laurence M	Jul/Aug 2018 Pg. 335-339
Atenolol 1 mg/mL or 5 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	May/Jun 2018 Pg. 233
Simvastatin 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	May/Jun 2018 Pg. 238
Spironolactone 5-mg/mL in Suspendit Oral Suspension Allen Loyd V Jr	Mar/Apr 2018 Pg. 152
Glutamate and Aspartate Cardioplegia Additive Solution Allen Loyd V Jr	Jan/Feb 2018 Pg. 50
Spironolactone 5 mg/mL in SuspendIt Oral Suspension Allen Loyd V Jr	Nov/Dec 2017 Pg. 496
Disopyramide 100-mg Capsules Allen Loyd V Jr	Jul/Aug 2017 Pg. 315
Reteplase Injection Allen Loyd V Jr	Jul/Aug 2017 Pg. 317
Torsemide 10-mg/mL Injection Allen Loyd V Jr	Jul/Aug 2017 Pg. 320
Stability of Spironolactone Oral Suspension in PCCA Base, SuspendIt Graves Richard, Phan Kelly V, Bostanian Levon A, Mandal Tarun K, Pramar Yashoda V	Jul/Aug 2017 Pg. 334-338
Candesartan Cilexetil 0.1-mg/mL to 2.0-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2017 Pg. 232
Candesartan Cilexetil 8 mg Liquid-Filled Capsules Allen Loyd V Jr	Mar/Apr 2017 Pg. 147
Furosemide 10-mg/mL Oral Suspension Allen Loyd V Jr	Mar/Apr 2017 Pg. 148
Stability of Alprostadil in 0.9% Sodium Chloride Stored in Polyvinyl Chloride Containers McCluskey Susan V, Kirkham Kylian, Munson Jessica M	Mar/Apr 2017 Pg. 150-153
Diazoxide 10-mg/mL Oral Suspension Allen Loyd V Jr	Jan/Feb 2017 Pg. 61
Bosentan 6.25-mg/mL Oral Suspension Allen Loyd V Jr	Nov/Dec 2016 Pg. 505
Melatonin 2-mg/mL Oral Suspension Allen Loyd V Jr	Nov/Dec 2016 Pg. 512
Inamrinone 5-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2016 Pg. 408
Stability of Sodium Nitroprusside in 5% Dextrose Stored at 4°C in Polypropylene Syringes Protected from Light Anderson Collin R, Collins Deborah, Laursen Trevor, Arave Trevor, Helm Michael	Sep/Oct 2016 Pg. 435-437
Case Report: Pediatric Scar Management After Open-heart Surgery Phan Ha, Harger Beau, Estrada Nick	Jul/Aug 2016 Pg. 277-280
Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures Foushee Jaime A, Meredith Pmichaele, Fox Laura M, Grace EdwardE	Jul/Aug 2016 Pg. 328-332
Physical and Chemical Stability of Urapidil in 0.9% Sodium Chloride in Elastomeric Infusion Pump Tomasello Cristina, Leggieri Anna, Rabbia Franco, Veglio Franco, Baietto Lorena, Fulcheri Chiara, De Nicolò Amedeo, De Perri Giovanni, D'Avolio Antonio	Jul/Aug 2016 Pg. 343-346
Sodium Nitroprusside 25-mg/mL Injection Allen Loyd V Jr	May/Jun 2016 Pg. 234
Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children Nahata Milap C	May/Jun 2016 Pg. 247-249
Carvedilol 3.125-mg, 6.25-mg, 12.5 mg, or 25-mg capsules Allen Loyd V Jr	Mar/Apr 2016 Pg. 145
Propranolol Hydrochloride Capsules Allen Loyd V Jr	Nov/Dec 2015 Pg. 513
Compounding Pharmacies' Potential to Create Graft Storage Solutions for Bypass Surgeries Guth Michael AS	Sep/Oct 2015 Pg. 367-373
Nimodipine 3-mg/mL Oral Solution Allen Loyd V Jr	Sep/Oct 2015 Pg. 407
Estradiol: The Emerging Evidence for a Protective Role Against Insulin Resistance and Obesity Biundo Bruce, Gogola Margaret	Jul/Aug 2015 Pg. 289-293
Compounded Testosterone Troches to optimize Health and the Testosterone Controversy Guth Michael AS	May/Jun 2015 Pg. 195-203
Aminohippurate Sodium 200-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2015 Pg. 143
Heparin 335-United/Gram Gel-Cream Allen Loyd V Jr	Mar/Apr 2015 Pg. 145
Morrhuate Sodium 5% Injection Allen Loyd V Jr	Mar/Apr 2015 Pg. 147
Transdermal Delivery of Nisoldipine: Refinement of Vehicles El Maghraby Gamal M, Ahmed Amal A, Osman Mohamed A	Mar/Apr 2015 Pg. 152-160
Atenolol 25-, 50-, or 100-mg Capsules Allen Loyd V Jr	Jan/Feb 2015 Pg. 60
Hydralazine Hydrochloride 20-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2015 Pg. 65
Phentolamine Mesylate 5-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2015 Pg. 69
Ephedrine Sulfate 50-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2014 Pg. 411
Indocyanine green 2.5-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2014 Pg. 413
Chlorothiazide 50-mg/mL Oral Suspension Allen Loyd V Jr	Jul/Aug 2014 Pg. 326
Propranolol Hydrochloride 1-mg/mL Injection Allen Loyd V Jr	Jul/Aug 2014 Pg. 330
Literature Review: The Dual Role of Domperidone in Gastroparesis and Lactation Phan Ha, DeReese Annie, Day A J, Carvalho Maria	May/Jun 2014 Pg. 203-207
Atorvastatin 10-mg or 20-mg Capsules Allen Loyd V Jr	May/Jun 2014 Pg. 232
Bumetanide 0.5-mg, 1-mg, or 2-mg Capsules Allen Loyd V Jr	May/Jun 2014 Pg. 233
Doxazosin 1-mg, 2-mg, 4-mg, or 8-mg Capsules Allen Loyd V Jr	Mar/Apr 2014 Pg. 142
Chemical and Physical Compatibility of an Intravenous Solution of Epinephrine with Calcium Chloride Weeks Phillip A, Teng Yang, Wu Lei, Sun Mary, Yang Zhen, Chow Diana S-L	Mar/Apr 2014 Pg. 152-158
Preparation and Stability Evaluation of Extemporaneous Oral Suspension of Valsartan Using Commercially Available Tablets Zaid Abdel Naser, Assali Mohyeddin, Qaddomi Aiman, Ghanem Mashhour, Zaaror Yara Abu	Mar/Apr 2014 Pg. 169-174
Bumetanide 0.25-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2014 Pg. 61
Nimodipine 30-mg Capsules Allen Loyd V Jr	Jan/Feb 2014 Pg. 65
Potassium Chloride 2-mEq/mL Injection Allen Loyd V Jr	Jan/Feb 2014 Pg. 67
Procainamide Hydrochloride 100-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2014 Pg. 68
Stability of Nitroglyercin 100 mcg/mL Stored in Polypropylene Syringes McCluskey Susan V, Vu Nicole, Rueter John	Nov/Dec 2013 Pg. 515-519
Indomethacin 1-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2013 Pg. 419
Phenylephrine Hydrochloride 10-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2013 Pg. 422
Compatibility of Amiodarone Hydrochloride with Vasopressin During Simulated Y-site Administration Ramaley Corrine C, Li Feng, Du Chengan	Sep/Oct 2013 Pg. 436-438
Metoprolol Tartrate 1-mg/mL Injection Allen Loyd V Jr	Jul/Aug 2013 Pg. 333
Stability of Captopril in SyrSPend SF Geiger Christine M, Sorenson Bridget, Whaley Paul A	Jul/Aug 2013 Pg. 336-338
Labetalol 50-mg Capsules Allen Loyd V Jr	May/Jun 2013 Pg. 233
Reserpine 0.5-mg Capsules Allen Loyd V Jr	May/Jun 2013 Pg. 237
Adenosine 3-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2013 Pg. 144
Dexrazoxane 1-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2013 Pg. 149
Verapamil Hydrochloride 2.5-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2013 Pg. 153
Treatment of Canine Pulmonary Hypertension: Is Tadalafil an Appropriate Alternative to Sildenafil? Wung Deanna	Jan/Feb 2013 Pg. 24-27
Dobutamine 10-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2013 Pg. 65
Milrinone 0.2-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2013 Pg. 69
Nicardipine Hydrochloride Injection Allen Loyd V Jr	Jan/Feb 2013 Pg. 71
Dipyridamole 5-mg/mL Injection Allen Loyd V Jr	Nov/Dec 2012 Pg. 504
Stability of Propranolol Hydrochloride in SyrSpend SF Geiger Christine M, Voudrie Mark A II, Sorenson Bridget	Nov/Dec 2012 Pg. 513-515
Enalaprilat 1.25-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2012 Pg. 419
Esmolol Hydrochloride 10-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2012 Pg. 420
Methyldopate Hydrochloride 50-mg/mL Injection Allen Loyd V Jr	Jul/Aug 2012 Pg. 338
Formulation and Stability Evaluation of Extemporaneously Prepared Atenolol Capsules from Crushed Atenolol Tablets Zaid Abdel Naser, Malkieh Numan, Kharoaf Maher, Ghoush Abeer Abu, Al-Ramahi Rowa'	Jul/Aug 2012 Pg. 342-346
A Concise Discussion of Headache Types, Part 2: Migraine Williams LaVonn A	May/Jun 2012 Pg. 182-188
Diltiazem Hydrochloride 5-mg/mL Injection Allen Loyd V Jr	May/Jun 2012 Pg. 241
Amiodarone Hydrochloride 50-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2012 Pg. 154
Furosemide 10-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2012 Pg. 158
Labetalol Hydrochloride 5-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2012 Pg. 160
Chemical Stability of Pentoxifylline in a Topical Cream Gupta Vishnu D	Jan/Feb 2012 Pg. 80-81
Glutaraldehyde-treated Autologous Pericardium Used in Valve Repairs McElhiney Linda F	Jan/Feb 2012 Pg. 12-16
Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension Helms Scott R, Fox Samantha, Mixon William, Vail Jane	Jan/Feb 2012 Pg. 34-41
Magnesium Sulfate 10% Injection (0.8 mEq/mL) Allen Loyd V Jr	Jan/Feb 2012 Pg. 72
Infantile Hemangiomas, Part 1: Treatment with Oral Propranolol Hydrochloride Zur Eyal	Sep/Oct 2011 Pg. 358-366
Carvedilol 0.625-mg/mL Oral Liquid Allen Loyd V Jr	Sep/Oct 2011 Pg. 418
Metoprolol Tartrate 1.25-mg/mL Oral Liquid Allen Loyd V Jr	Sep/Oct 2011 Pg. 421
Nifedipine 1-mg/500-mg Oral Powder Allen Loyd V Jr	Sep/Oct 2011 Pg. 422
Nifedipine 10-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 2011 Pg. 423
Sotalol 5-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 2011 Pg. 425
Impact of Conventional and Bioidentical Hormone Replacement Therapy on Cardiovascular and Breast Health: A Review Ruiz Andres D, Daniels Kelly R, Barner Jamie C, Carson John J, Frei Christopher R	Jul/Aug 2011 Pg. 290-300
Stability of Verapamil Hydrochloride in SyrSpend SF Compared to Sorbitol Containing Syrup and Suspending Vehicles Voudrie Mark A, Alexander Bridget, Allen D Brett	May/Jun 2011 Pg. 255-258
Compatibility of Parenteral Furosemide with Seventeen Secondary Drugs Used in Standard Concentrations Jasti Bhaskara R, Saraf Poonam	May/Jun 2011 Pg. 259-261
Clopidogrel 5-mg/mL Oral Suspension Allen Loyd V Jr	Mar/Apr 2011 Pg. 158
Nifedpine in Compounded Oral and Topical Preparations McCluskey Susan V, Brunn Gregory J	Mar/Apr 2011 Pg. 166-169
Sodium Nitroprusside and Sodium Thiosulfate Intravenous Admixture Allen Loyd V Jr	Jan/Feb 2011 Pg. 71
Case Report: Management of Secondary Hypertension in a Feline with the Use of Transdermal Prazosin Rudner Shara, Browne Paul	Nov/Dec 2010 Pg. 488-491
The Clinical Use of Dehydroepiandrosterone in Postmenopausal Women Bramwell Bethany L	Nov/Dec 2010 Pg. 465-471
Carvedilol 1-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 2010 Pg. 423
Fenoldopam Mesylate Injection Allen Loyd V Jr	Jul/Aug 2010 Pg. 340
Emerging Evidence for Androgen Replacement Therapy in Aging Men Bramwell Bethany L	Mar/Apr 2010 Pg. 94-99
Coenzyme Q10 Supplementation in the Treatment of Heart Disease Bramwell Bethany L	Mar/Apr 2010 Pg. 108-111
Metolazone 10-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2010 Pg. 157
Providing Consultation Services for Wellness Issues Related to Exercise, Weight Management, and Nutritional Support: Key Lifestyle Modification for Healthier Aging Biundo Bruce	Jan/Feb 2010 Pg. 26-31
Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis Muller George, Young Thomas W, Reina Rachel, Caldwell Delmar R	Jan/Feb 2010 Pg. 40-45
Low Testosterone in Older Men: A Discussion and Review of Literature on Health Consequences of Hypogonadism in the Aging Male Biundo Bruce	Nov/Dec 2009 Pg. 494-496
Congestive Heart Failure and Other Medical Facts About Ferrets; Scout's Story: A Case Report on Treating Congestive Heart Failure in a Ferret Williams LaVonn A, Riley Kari	Sep/Oct 2009 Pg. 367-371
Amlodipine Besylate 1 mg/mL Veterinary Suspension Allen Loyd V Jr	Sep/Oct 2009 Pg. 429
Dexamethasone and Furosemide Injection Allen Loyd V Jr	Jul/Aug 2009 Pg. 335
Elegant Compounded Solutions for the Treatment of Thrombosed External Hemorrhoids Zur Eyal	May/Jun 2009 Pg. 192-195
Vasopressin Tannate 5 Pressor Units Per mL in Oil Injection Allen Loyd V Jr	Mar/Apr 2009 Pg. 161
Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases Mixon William, Helms Scott R	Sep/Oct 2008 Pg. 392-397
Carnitine 400-mg/mL and Coenzyme Q10 10-mg/mL Solution Allen Loyd V Jr	Sep/Oct 2008 Pg. 448
Propafenone 1.5-mg/mL Oral Liquid Allen Loyd V Jr	Sep/Oct 2008 Pg. 455
Valsartan 4-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 2008 Pg. 269
Diltiazem 5% in Lipoderm, Veterinary Allen Loyd V Jr	Jan/Feb 2008 Pg. 67
Pentoxifylline 20-mg/mL Oral Suspension Allen Loyd V Jr	Jan/Feb 2008 Pg. 70
Benazepril 2-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 2007 Pg. 242
Folic Acid 1-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 2007 Pg. 244
Losartan Potassium 2.5-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 2007 Pg. 248
Compounded Treatments for Erectile Dysfunction: A Common Complication of Diabetes Fields Shannon W	Mar/Apr 2007 Pg. 122-124
Aspirin 80-mg/5-mL Oral Liquid, Anhydrous Allen Loyd V Jr	Mar/Apr 2007 Pg. 154
Phenoxybenzamine Hydrochloride 2-mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 2007 Pg. 160
Clonidine Hydrochloride 0.1-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2007 Pg. 71
Methyldopa 25-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2007 Pg. 75
Metolazone 1-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2007 Pg. 76
Hydralazine Hydrochloride 1-mg/mL or 10-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2006 Pg. 457
Application of Sildenafil for Pulmonary Hypertension in Canines and Foals Davidson Gigi S	Nov/Dec 2006 Pg. 405-408
Taurine for the Treatment of Canine Dilated Cardiomyopathy Vail Jane	Nov/Dec 2006 Pg. 421-424
Amiloride Hydrochloride 1-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2006 Pg. 452
Lisinopril 1-mg/mL, Sodium Citrate, and Citric Acid Oral Liquid Allen Loyd V Jr	Sep/Oct 2006 Pg. 386
Lisinopril 1-mg/mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2006 Pg. 302
Nifedipine 4-mg/mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2006 Pg. 303
Propranolol Hydrochloride 1-mg/mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2006 Pg. 304
Sildenafil Citrate 2.5-mg/mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2006 Pg. 306
Carvedilol 1.25-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2006 Pg. 220
Enalapril Maleate 1-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2006 Pg. 221
Mexiletine Hydrochloride 10-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2006 Pg. 225
Quinapril 1-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 2006 Pg. 227
Amlodipine 1-mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 2006 Pg. 137
Disopyramide Phosphate 1-mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 2006 Pg. 140
Sotalol Hydrochloride 5-mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 2006 Pg. 144
Isradipine 1-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2005 Pg. 477
Quinidine Sulfate 10-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2005 Pg. 479
Chemical Stability of Hydralazine Hydrochloride after Reconstruction in 0.9% Sodium Chloride Injection or 5% Dextrose Injection for Infusion Gupta Vishnu D	Sep/Oct 2005 Pg. 399-401
Stability of Sotalol Hydrochloride in Extemporaneously Prepared Oral Suspension Formulations Sidhom Madiha B, Rivera Nadya, Almoazen Hassan, Taft David R, Kirschenbaum Harold L	Sep/Oct 2005 Pg. 402-406
Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs Harrington Catherine A, Cauffield Jacintha	May/Jun 2005 Pg. 201-205
Return to Top